ATE399001T1 - Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel - Google Patents
Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittelInfo
- Publication number
- ATE399001T1 ATE399001T1 AT03775466T AT03775466T ATE399001T1 AT E399001 T1 ATE399001 T1 AT E399001T1 AT 03775466 T AT03775466 T AT 03775466T AT 03775466 T AT03775466 T AT 03775466T AT E399001 T1 ATE399001 T1 AT E399001T1
- Authority
- AT
- Austria
- Prior art keywords
- spheroids
- production process
- products containing
- medicinal products
- spheroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212333A FR2845289B1 (fr) | 2002-10-04 | 2002-10-04 | Spheroides, procede de preparation et compositions pharmaceutiques. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE399001T1 true ATE399001T1 (de) | 2008-07-15 |
Family
ID=32011398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03775466T ATE399001T1 (de) | 2002-10-04 | 2003-10-03 | Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel |
Country Status (17)
Country | Link |
---|---|
US (2) | US20060165794A1 (de) |
EP (1) | EP1549298B1 (de) |
JP (1) | JP4660192B2 (de) |
CN (1) | CN1713896B (de) |
AT (1) | ATE399001T1 (de) |
AU (1) | AU2003283492A1 (de) |
CA (1) | CA2501294C (de) |
CY (1) | CY1108285T1 (de) |
DE (1) | DE60321801D1 (de) |
DK (1) | DK1549298T3 (de) |
ES (1) | ES2307993T3 (de) |
FR (1) | FR2845289B1 (de) |
HK (1) | HK1077023A1 (de) |
MX (1) | MXPA05003588A (de) |
PT (1) | PT1549298E (de) |
SI (1) | SI1549298T1 (de) |
WO (1) | WO2004030657A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1621187A1 (de) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung |
US20100015239A1 (en) * | 2008-07-17 | 2010-01-21 | Ahmed Salah U | Orally Disintegrating Solid Pharmaceutical Dosage Forms Comprising Delayed-Release Lansoprazole and Methods of Making and Using the Same |
CN102858187B (zh) * | 2010-04-26 | 2015-01-14 | 帝斯曼知识产权资产管理有限公司 | 新型涂层系统 |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
MX2013009253A (es) * | 2011-02-11 | 2013-12-16 | Zx Pharma Llc | Formulaciones multiparticuladas de l-mentol y metodos relacionados. |
CA2881992C (en) | 2013-04-23 | 2016-11-22 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
ITMI20132066A1 (it) * | 2013-12-11 | 2015-06-12 | Farmatron Ltd | Sistemi terapeutici a rilascio modificato per la somministrazione orale di mentolo nel trattamento delle malattie intestinali |
WO2016205701A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Enteral fast access tract platform system |
US10631564B2 (en) | 2015-06-19 | 2020-04-28 | University Of Southern California | Enterically coated microparticle compositions and methods for modified nutrient delivery |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
IT202100006893A1 (it) * | 2021-03-22 | 2022-09-22 | Kolinpharma S P A | Una formulazione in forma di microgranuli comprendente un estratto o molecola di origine vegetale avente effetti gastrolesivi o instabilità a ph acido, e una matrice gastroresistente |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755387A (en) * | 1985-03-21 | 1988-07-05 | The Procter & Gamble Company | Therapeutic particles |
LU86099A1 (fr) * | 1985-09-30 | 1987-04-02 | Pharlyse | Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant |
GB8705083D0 (en) * | 1987-03-04 | 1987-04-08 | Euro Celtique Sa | Spheroids |
KR100354702B1 (ko) * | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US5780055A (en) * | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
UA77145C2 (en) | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
FR2774288B1 (fr) * | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
FR2793688B1 (fr) * | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
US6419954B1 (en) * | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
DE10044299A1 (de) * | 2000-09-07 | 2002-03-21 | Roehm Gmbh | Multipartikuläre Arzneiform und Verfahren zu ihrer Herstellung |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
-
2002
- 2002-10-04 FR FR0212333A patent/FR2845289B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-03 DE DE60321801T patent/DE60321801D1/de not_active Expired - Lifetime
- 2003-10-03 CN CN2003801037982A patent/CN1713896B/zh not_active Expired - Fee Related
- 2003-10-03 DK DK03775466T patent/DK1549298T3/da active
- 2003-10-03 JP JP2004540887A patent/JP4660192B2/ja not_active Expired - Fee Related
- 2003-10-03 AT AT03775466T patent/ATE399001T1/de active
- 2003-10-03 EP EP03775466A patent/EP1549298B1/de not_active Expired - Lifetime
- 2003-10-03 SI SI200331253T patent/SI1549298T1/sl unknown
- 2003-10-03 PT PT03775466T patent/PT1549298E/pt unknown
- 2003-10-03 AU AU2003283492A patent/AU2003283492A1/en not_active Abandoned
- 2003-10-03 ES ES03775466T patent/ES2307993T3/es not_active Expired - Lifetime
- 2003-10-03 US US10/530,052 patent/US20060165794A1/en not_active Abandoned
- 2003-10-03 CA CA2501294A patent/CA2501294C/fr not_active Expired - Fee Related
- 2003-10-03 MX MXPA05003588A patent/MXPA05003588A/es active IP Right Grant
- 2003-10-03 WO PCT/FR2003/002909 patent/WO2004030657A1/fr active IP Right Grant
-
2005
- 2005-12-20 HK HK05111773A patent/HK1077023A1/xx not_active IP Right Cessation
-
2008
- 2008-08-25 CY CY20081100901T patent/CY1108285T1/el unknown
-
2010
- 2010-04-23 US US12/766,176 patent/US9446002B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4660192B2 (ja) | 2011-03-30 |
FR2845289B1 (fr) | 2004-12-03 |
MXPA05003588A (es) | 2005-07-25 |
SI1549298T1 (sl) | 2008-08-31 |
CA2501294A1 (fr) | 2004-04-15 |
HK1077023A1 (en) | 2006-02-03 |
DK1549298T3 (da) | 2008-09-22 |
EP1549298B1 (de) | 2008-06-25 |
US20100203134A1 (en) | 2010-08-12 |
EP1549298A1 (de) | 2005-07-06 |
FR2845289A1 (fr) | 2004-04-09 |
PT1549298E (pt) | 2008-09-16 |
CA2501294C (fr) | 2013-03-26 |
US20060165794A1 (en) | 2006-07-27 |
US9446002B2 (en) | 2016-09-20 |
AU2003283492A1 (en) | 2004-04-23 |
ES2307993T3 (es) | 2008-12-01 |
DE60321801D1 (de) | 2008-08-07 |
CY1108285T1 (el) | 2014-02-12 |
CN1713896B (zh) | 2011-12-28 |
CN1713896A (zh) | 2005-12-28 |
JP2006505540A (ja) | 2006-02-16 |
WO2004030657A1 (fr) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108285T1 (el) | Σφαιροειδη, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις | |
BRPI0409652A (pt) | tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete | |
WO2003090726A3 (en) | Chewable soft capsule | |
BR0106912A (pt) | Partìculas contendo ingrediente ativo | |
AR014753A1 (es) | Formulacion farmaceutica que contiene un 2-[[(2-piridinil)metil]sulfinil] bencimidazol que tiene una actividad antiulcerosa, y un proceso para lapreparacion de dicha formulacion | |
MA27320A1 (fr) | Medicament contenant du trihydrate d'hydrochlorure de vardenfil | |
KR870010865A (ko) | 피복된 복용 형태 | |
BR0206441A (pt) | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação | |
PE4796A1 (es) | Formas de dosificacion de liberacion controlada de azitromicina | |
ES2189868T3 (es) | Microesferas y nanoesferas biodegradables de liberacion controlada que contienen ciclosporina. | |
DE69634693D1 (de) | Mehrfach ungesättigte omega-3 fettsäuren zur behandlung von entzündlichen darmerkrankungen in kapseln mit zeitabhängiger freisetzung | |
PL356962A1 (en) | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet | |
ATE457719T2 (de) | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel | |
WO2006125620A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
WO2008000731A3 (en) | Pharmaceutical composition for the oral administration of omega polyenoic fatty acids | |
AR003463A1 (es) | Una formulacion de liberacion controlada o de liberacion retardada; su utilizacion en la fabricacion de un medicamento y un procedimiento para su preparacion. | |
ATE316779T1 (de) | Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung | |
ATE390138T1 (de) | Dipyridamol enthaltende zusammensetzungen mit verlängerter freisetzung und verfahren zu deren herstellung | |
AR021578A1 (es) | Formulacion en perlas de pravastatina con revestimiento enterico | |
ATE442852T1 (de) | Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung | |
UY25192A1 (es) | Formulación medicamentosa con liberación controlada de sustancia activa | |
BRPI0412697A (pt) | composições farmacêuticas que apresentam um revestimento expansìvel | |
BR9913782A (pt) | Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato | |
MY143793A (en) | Non-tabletted, chewable, individually dosed administration forms | |
BR0304463A (pt) | Processos para a produção de ésteres de ácidos carboxìlicos insaturados, e para a produção de ácidos carboxìlicos insaturados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1549298 Country of ref document: EP |